Browse drugs

…w-up from diagnosis of 21 (IQR 14–29) months, 124 (91%) started antibiotics for NTM-PD. Forty-five (33%) remain on follow-up and using anti…

…worsen the condition, treatment with inhaled steroids (ICS) and beta-agonists dampen these responses. As treatment adherence is non-linear, u…

…onditions, especially primary lung cancer, is clear.Clinically, EBUS-TBNA provides genetic diagnoses, which can enable immunotherapy. Pat…

…one had a significantly higher discontinuation risk compared to nintedanib (HR 1.60, 95% CI 1.05–2.44, p=0.029).121 patients (44%) died be…

…t the BTS winter conference.Conclusion This study suggests that intrapleural fibrinolytics visibly reduce pleural septations on ultrasound in patients wit…

…ptimisation, supporting low-risk asthma patients to switch from Fostair 100/6 MDI to Fobumix Easyhaler DPI.Methods Eligible patients were identif…

…from approaches utilising separate ICS-containing preventer and SABA reliever inhalers. SENTINEL is a quality improvement framework …

… salts and colophony have remained relatively stable. Latex and pharmaceuticals are no longer frequent causes of OA in our service. ( figure 1)…

…re: pneumothorax 80% (132/165), PE 85.3% (515/604), and PE with cor pulmonale 93.4% (155/166). Inter-reviewer reliability for decisions regar…

…ycin Therapy) trial. This trial compares continuing vs stopping azithromycin therapy in patients with non-cystic fibrosis bronchiectasis. Th…

… in the level of D-dimers in the presence of the PAD4 inhibitor GSK484, tPA and Dnase (p= 0.0003), confirming the contribution of citr…

…Conclusion This cross-sectional study emphasised the persistent OCS use in CRSwNP management, even as biologics are emerging as an …